Biological response modifiers used in cancer biotherapy

Area of Science:

• Immunology
• Oncology
• Pharmacology

Background:

• Biotherapy leverages the body's natural immune system for therapeutic benefits.
• It utilizes biological response modifiers (BRMs) such as vaccines, monoclonal antibodies, and cytokines.
• BRMs can be used independently or in combination for various medical conditions.

Purpose of the Study:

• To define biotherapy and its mechanisms of action.
• To outline the role of biological response modifiers (BRMs) in medical treatments.
• To discuss the application and side-effect profile of biotherapy, particularly in oncology.

Main Methods:

• Review of existing literature on biotherapy and biological response modifiers (BRMs).
• Analysis of the components and functions of BRMs.
• Examination of clinical applications and reported side effects.

Main Results:

• Biotherapy utilizes BRMs to enhance immune responses against diseases like cancer.
• Several BRMs are established treatments for specific cancers, with others under investigation.
• Reported side effects are agent- and patient-dependent but generally transient.

Conclusions:

• Biotherapy represents a significant approach in managing infections and cancers by modulating immune responses.
• Biological response modifiers (BRMs) are key components of biotherapy with diverse applications.
• Understanding and managing the side effects of biotherapy is crucial for patient care, as they are typically temporary.